Our | Products


Hidroxiurea Varifarma





THERAPEUTIC AREA: Oncology / Hematology
ACTIVE PRINCIPLE: Hydroxyurea
PRESENTATION: 500 mg x 100 capsules
INDICATION:

  • Myeloid Splenomegaly
  • Chronic Myeloid Leukemia
  • Myelofibrosis
  • Primitive Polyglobulia
  • Essential Thrombocythemia